文献速递冠心病外科

冠状动脉旁路移植术中三支及以上动脉桥的增量价值:自体血管病变程度的影响

The Incremental Value of Three or More Arterial Grafts in CABG: The Effect of Native Vessel Disease.
PubMed 文献 · Ann Thorac Surg · 2018-07-03

分析11,931例多支病变行左内乳动脉至左前降支搭桥且桥血管≥2支的患者,按动脉桥数量分组比较15年生存。全队列中动脉桥越多生存越好(三支HR 0.75,95%CI 0.65–0.85),获益集中于三支病变(三支HR 0.73,95%CI 0.63–0.84),双支病变无生存获益。

要点

  • 全队列中三支动脉桥较低生存改善(HR 0.75,95%CI 0.65–0.85)。
  • 三支病变患者三支动脉桥获益更明显(HR 0.73,95%CI 0.63–0.84)。
  • 双支病变患者未观察到附加动脉桥的生存获益。

核心结论

  • 结果支持使用扩展动脉桥以最大化冠状动脉旁路移植术患者的长期生存,尤其对三支病变患者。

研究设计与样本

  • 对11,931例多支病变、行初次孤立左内乳动脉至左前降支搭桥且桥血管≥2支的患者分析15年死亡率。
  • 患者年龄64.3±10.5岁,女性3,484例(29.2%),双支病变2,532例(21.2%),三支病变9,399例(78.8%)。
  • 分为单支动脉组(n=6,782,56.9%,参照组)、两支动脉组(n=3,678,30.8%)和三支动脉组(n=1,471,12.3%)。
  • 用Kaplan-Meier估计比较长期生存,用协变量校正Cox回归得出风险校正死亡风险比(HR)及95%置信区间(CI)。

主要发现

  • 附加动脉桥使用桡动脉(94%)和右内乳动脉(6%)。
  • 全多支病变队列中,动脉桥数量增加与15年生存逐步改善相关:两支动脉HR 0.85(95%CI 0.78–0.92),三支动脉HR 0.75(95%CI 0.65–0.85)。
  • 三支动脉与两支动脉比较一致但未达统计学显著(HR 0.89,95%CI 0.77–1.03)。
  • 三支病变患者中附加动脉桥获益更明显:两支动脉HR 0.84(95%CI 0.76–0.92),三支动脉HR 0.73(95%CI 0.63–0.84)。
  • 双支病变患者中未观察到附加动脉桥的生存获益。

临床怎么用

  • 作者结论支持使用扩展动脉桥以最大化冠状动脉旁路移植术患者的长期生存,尤其对三支病变患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated whether extended arterial grafting with three or more arterial grafts in patients with a left internal thoracic artery to left anterior descending artery graft improves survival in coronary artery bypass graft surgery patients and whether its effects will depend on the extent of coronary artery disease; specifically three-vessel disease (3VD) versus two-vessel disease (2VD). METHODS: Fifteen-year mortality was analyzed in 11,931 patients with multivessel disease and primary isolated left internal thoracic artery to left anterior descending artery coronary artery bypass graft surgery with 2 or more grafts. Patients were aged 64.3 ± 10.5 years; 3,484 (29.2%) were women; 2,532 (21.2%) had 2VD and 9,399 (78.8%) had 3VD. Patients were grouped into one single-artery group (n = 6,782, 56.9%; reference group), and two multiple artery groups: two arteries (n = 3,678, 30.8%) and three arteries (n = 1,471, 12.3%). Long-term survival was compared by Kaplan-Meier estimates. Risk-adjusted mortality hazard ratio (HR) with 95% confidence interval (CI) were derived by covariate adjusted Cox regression to quantify multiple artery effects versus one artery in the overall cohort and separately among patients with 2VD and 3VD. RESULTS: Radial artery (94%) and right internal thoracic artery (6%) conduits were used for additional arterial grafts. For the entire multivessel cohort, increasing number of arterial grafts was associated with incrementally improved 15-year survival (two arteries HR 0.85, 95% CI: 0.78 to 0.92; three arteries HR 0.75, 95% CI: 0.65 to 0.85). The three arteries versus two arteries comparison was consistent, even if not significant (HR 0.89, 95% CI: 0.77 to 1.03). The benefits derived from additional arterial grafts were more pronounced in case of 3VD (two arteries HR 0.84 95% CI: 0.76 to 0.92; three arteries HR 0.73, 95% CI: 0.63 to 0.84), without survival benefit with 2VD. CONCLUSIONS: Our results support the use of extended arterial grafting to maximize long-term coronary artery bypass graft surgery patient survival, especially for 3VD patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Schwann TA, El Hage Sleiman AKM, Yammine MB, et al. The Incremental Value of Three or More Arterial Grafts in CABG: The Effect of Native Vessel Disease. Ann Thorac Surg. 2018. PMID: 30244703. doi:10.1016/j.athoracsur.2018.05.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。